2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of …
Authors/Task Force Members, SG Priori… - Ep …, 2015 - academic.oup.com
The present document has been conceived as the European update to the American
College of Cardiology (ACC)/American Heart Association (AHA)/ESC 2006 Guidelines for …
College of Cardiology (ACC)/American Heart Association (AHA)/ESC 2006 Guidelines for …
The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the …
P Lancellotti, PA Pellikka, W Budts… - European Heart …, 2016 - academic.oup.com
A unique and highly versatile technique, stress echocardiography (SE) is increasingly
recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for …
recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for …
Development and validation of a risk score to predict QT interval prolongation in hospitalized patients
JE Tisdale, HA Jaynes, JR Kingery… - … Quality and Outcomes, 2013 - Am Heart Assoc
Background—Identifying hospitalized patients at risk for QT interval prolongation could lead
to interventions to reduce the risk of torsades de pointes. Our objective was to develop and …
to interventions to reduce the risk of torsades de pointes. Our objective was to develop and …
Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine
D De Berardis, G Rapini, L Olivieri… - … advances in drug …, 2018 - journals.sagepub.com
Clozapine, a dibenzodiazepine developed in 1961, is a multireceptorial atypical
antipsychotic approved for the treatment of resistant schizophrenia. Since its introduction, it …
antipsychotic approved for the treatment of resistant schizophrenia. Since its introduction, it …
[HTML][HTML] QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes
K Wenzel-Seifert, M Wittmann… - Deutsches Ärzteblatt …, 2011 - ncbi.nlm.nih.gov
Method We searched PubMed for pertinent literature on the risk of QTc prolongation and/or
TdP associated with commonly used psychotropic drugs. Results Thioridazine and …
TdP associated with commonly used psychotropic drugs. Results Thioridazine and …
Anxiety in patients with schizophrenia: Epidemiology and management
H Temmingh, DJ Stein - CNS drugs, 2015 - Springer
Anxiety symptoms can occur in up to 65% of patients with schizophrenia, and may reach the
threshold for diagnosis of various comorbid anxiety disorders, including obsessive …
threshold for diagnosis of various comorbid anxiety disorders, including obsessive …
Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents
CU Correll, JB Penzner, UH Parikh… - Child and …, 2006 - childpsych.theclinics.com
Despite the limited availability of randomized, controlled evidence regarding the efficacy and
safety of second-generation antipsychotics (SGAs) in pediatric populations [1, 2], this class …
safety of second-generation antipsychotics (SGAs) in pediatric populations [1, 2], this class …
QT alterations in psychopharmacology: proven candidates and suspects
PA Alvarez, J Pahissa - Current drug safety, 2010 - ingentaconnect.com
Psychotropics are among the most common causes of drug induced acquired long QT
syndrome. Blockage of Human ether-ago-go-related gene (HERG) potassium channel by …
syndrome. Blockage of Human ether-ago-go-related gene (HERG) potassium channel by …
Assessing QT interval prolongation and its associated risks with antipsychotics
Several antipsychotics are associated with the ventricular tachycardia torsade de pointes
(TdP), which may lead to sudden cardiac death (SCD), because of their inhibition of the …
(TdP), which may lead to sudden cardiac death (SCD), because of their inhibition of the …
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect-comprehensive overview of clinical trials
B Wiśniowska, Z Tylutki, G Wyszogrodzka… - BMC Pharmacology and …, 2016 - Springer
Background Proarrhythmia assessment is one of the major concerns for regulatory bodies
and pharmaceutical industry. ICH guidelines recommending preclinical tests have been …
and pharmaceutical industry. ICH guidelines recommending preclinical tests have been …